Melkersson–Rosenthal syndrome as an early manifestation of mixed connective tissue disease
نویسندگان
چکیده
منابع مشابه
Melkersson–Rosenthal syndrome as an early manifestation of mixed connective tissue disease
PURPOSE OF REVIEW We aim to illustrate the potential viability of MCTD as an underlying aetiology of Melkersson-Rosenthal syndrome. The case is probably the first description available in the literature of the Melkersson-Rosenthal as an early manifestation of mixed connective tissue disease. RECENT FINDINGS The Melkersson-Rosenthal syndrome consists of a triad of recurrent lip and/or face swe...
متن کاملPreliminary Neuropsychiatric Manifestation in Mixed Connective Tissue Disease
We report a case of 51 years old woman who suffered from mixed connective tissue disorder (MCTD), complicated by neuropsychiatric manifestation at her initial course of illness. This convoluted her case management, unless the diagnosed was confirmed by skin biopsy. She improved significantly and rapidly on steroid pulse. Neuropsychiatric characteristics are not common presentation in MCTD. Ther...
متن کاملSjögren's syndrome: An underdiagnosed condition in mixed connective tissue disease
OBJECTIVE To determine the prevalence of sicca symptoms, dry eye, and secondary Sjögren's syndrome and to evaluate the severity of dry eye in patients with mixed connective tissue disease. METHODS In total, 44 consecutive patients with mixed connective tissue disease (Kasukawa's criteria) and 41 healthy controls underwent Schirmer's test, a tear film breakup time test, and ocular surface stai...
متن کامل[Mixed connective tissue disease].
Mixed connective tissue disease deserves to be a distinct disease entity due to the persistent citation of this disease in the literature since the original description by Sharp in 1972, in spite of the presence of several criticisms against the independency of this disease. The characteristic features of mixed connective tissue disease are: 1) the presence of anti-U1snRNP antibody with high ti...
متن کاملB cell Therapy to Treat an Axonal Neuropathy in Mixed Connective Tissue Disease
The B cell is a vital contributor to humoral immunity. The B cell-specific antigen CD20 is expressed during B cell development, starting at the pre-B cell level and persists through B cell differentiation, but is lost during terminal differentiation to plasma cells. Rituximab is a monoclonal antibody that destroys both normal and malignant B cells that have CD20 on their surfaces and is ther...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Medical Research
سال: 2015
ISSN: 2047-783X
DOI: 10.1186/s40001-015-0192-7